Didgeridoo for sleep apnoea: how an Indigenous instrument became a credible therapy

Of all the unlikely tools to find their way into a sleep clinic, the didgeridoo would have to be near the top of the list. A ceremonial wind instrument from the Top End, played by Yolŋu and other First Nations peoples of northern Australia for thousands of years, has — over the past two decades — quietly become one of the more credible non-machine therapies for mild-to-moderate obstructive sleep apnoea (OSA).

It sounds like a novelty. It isn't. The reasoning behind it is mechanical, the early trial that put it on the map was published in a major medical journal, and the broader idea — that you can train the muscles of the upper airway to behave better at night — is now an active field of clinical research.

A breathing problem, not just a snoring problem

Obstructive sleep apnoea happens when the soft tissues at the back of the throat collapse during sleep, briefly blocking the airway. People stop breathing, oxygen levels dip, the brain partially rouses, and the cycle repeats — sometimes dozens of times an hour. Untreated, OSA is linked to daytime fatigue, hypertension, cardiovascular disease and increased crash risk.

The standard treatment is continuous positive airway pressure, or CPAP: a mask that splints the airway open with pressurised air. CPAP works, but adherence is famously patchy. Plenty of patients abandon their machines within a year because of mask discomfort, noise, claustrophobia or simple inconvenience. That gap — between an effective therapy and one people will actually use — is why researchers keep looking for alternatives.

As a recent Frontiers review on "modifying upper airway output" frames it, the future of OSA care is unlikely to be one-device-fits-all. Therapies that change the behaviour of the airway muscles themselves are attracting renewed clinical attention, alongside surgical and pharmacological options.

Why the didgeridoo, of all things

The didgeridoo is played using circular breathing: the player maintains a continuous drone by pushing air out with the cheeks while simultaneously inhaling through the nose. Sustaining that technique demands constant, controlled engagement of the tongue, soft palate, pharyngeal walls and diaphragm — exactly the muscle groups that go floppy in sleep apnoea.

That mechanistic logic is what drew Swiss researchers led by Milo Puhan to investigate the instrument as a therapy in the mid-2000s. Their randomised controlled trial, published in the BMJ in 2006, found that four months of regular didgeridoo lessons and home practice reduced daytime sleepiness and apnoea severity in adults with moderate OSA compared with a control group on a waiting list. Partners also reported less sleep disturbance.

Nearly twenty years later, the study still gets cited — and gently ribbed. As Improbable Research, the outfit behind the Ig Nobel Prizes, recently noted, the didgeridoo work continues to be referenced in newer reviews of snoring and OSA management. It is one of those rare papers that began life as a curiosity and matured into a legitimate citation.

From novelty to a category: myofunctional therapy

The bigger shift since 2006 is that the didgeridoo no longer looks like an outlier. It looks like an early, charismatic example of a whole category now called myofunctional therapy or oropharyngeal exercise — structured training of the tongue and throat muscles to improve airway tone.

A 2024 study published in Nature's Scientific Reports examined the effect of a brief, 10-minute daily oropharyngeal exercise programme on the apnoea–hypopnoea index (AHI) — the standard measure of how many breathing disruptions a patient has per hour of sleep. The trial found measurable improvements in AHI from a low-burden, no-equipment routine. That is a meaningfully different value proposition from CPAP: no mask, no electricity, no consumables.

The Frontiers review puts these approaches under a broader umbrella of strategies that act on "upper airway output" — that is, the neuromuscular drive keeping the airway patent — rather than on the air pressure inside it. A complementary Wiley piece argues for a more expansive approach to OSA, recognising that the condition has multiple causes (anatomical, muscular, neurological, positional) and therefore probably needs multiple, layered treatments rather than a single device.

Inside that framework, the didgeridoo is no longer a quirky one-off. It is one of the more demanding and entertaining ways to do what physiotherapists, dentists and sleep doctors are increasingly asking patients to do anyway: train the airway.

What the evidence does — and doesn't — say

It is worth being honest about the limits.

What the evidence does support is a more nuanced picture of OSA treatment than "mask or nothing." For Australians newly diagnosed with mild or moderate sleep apnoea — and for those who genuinely cannot tolerate CPAP — there is now a defensible, evidence-informed conversation to have with a sleep physician about airway training as part of the plan.

An Australian angle worth sitting with

There is something quietly remarkable about the cultural arc here. The didgeridoo (yidaki, in Yolŋu Matha) is a sacred and culturally significant instrument with strict traditional protocols around who plays it and how. Its appearance in a European medical journal as a possible OSA therapy is a reminder of how much practical knowledge sits inside Indigenous Australian traditions that Western medicine is only beginning to engage with on its own terms.

It also raises a question of credit and respect. The instrument's therapeutic value, to the extent it has one, flows directly from playing techniques developed and refined by First Nations musicians over millennia. Anyone considering picking one up as a wellness tool would do well to learn from Indigenous teachers and to understand the cultural context — not just the cheek-puffing mechanics.

The takeaway

The didgeridoo-for-apnoea story is often told as a punchline: play a funny instrument, snore less. The more accurate version is more interesting. A 2006 randomised trial took an unconventional hypothesis seriously, found a real effect, and helped seed a now-mainstream research direction into training the upper airway as a treatment in its own right.

For patients, the practical message is simple. CPAP remains the gold standard for moderate-to-severe OSA, but it is no longer the only door in the building. Oropharyngeal exercises — whether through a structured 10-minute daily routine, formal myofunctional therapy, or, yes, learning to play the didgeridoo — are a credible part of the modern toolkit. The cure for a 21st-century health problem may turn out to involve a 40,000-year-old instrument. That is not a punchline. That is good medicine catching up.

Related on Bleen

Sources